LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Appeals Court Reinstates Zimmer Biomet Design-Defect Suit
Legal & Regulatory and Reimbursement

Appeals Court Reinstates Zimmer Biomet Design-Defect Suit

December 6, 2019 2 min read Premium comments

Advertisement

Appeals Court Reinstates Zimmer Biomet Design-Defect Suit
Source: pixabay/mohamed_hassan
#zimmerbiometSecondary#designdefect#hipimplant

A federal appeals court has reinstated a woman’s design-defect suit against Zimmer Biomet over a faulty hip prosthesis that was implanted in her in 2011.

In September 2010, Marilyn Adams consulted with orthopedic surgeon Prodromos Ververeli, M.D. regarding her history of right hip pain. On January 18, 2011, Dr. Ververeli performed a total right hip replacement surgery on Adams. Dr. Ververeli replaced Adams’ right hip with a Zimmer hip prosthesis consisting of several separate pieces.

Following the surgery, Adams initially experienced no pain. However, in late 2012, Adams began to experience severe pain, which Dr. Ververeli helped treat.

In 2014, Adams continued to have hip issues.

In early January 2015, Dr. Ververeli ordered a CT scan, which showed a local adverse tissue reaction.

On January 30, 2015, Dr. Ververeli determined that Adams was suffering from right total hip metallosis (the deposition and build-up of metal debris in the soft tissues of the body) and an adverse tissue reaction.

Dr. Ververeli recommended hip revision surgery for Adams to replace the femoral head of her hip implant.

On February 12, 2015, Dr. Ververeli performed Adams’ hip revision surgery. During the surgery, Dr. Ververeli’s discovery regarding Adams’ implant called for a more drastic revision than initially anticipated. During surgery, Dr. Ververeli discovered that Adams’ implant had deteriorated and emitted metal shards into her hip.

Advertisement

After surgery, on February 12, 2015, Dr. Ververeli informed Adams of his intraoperative finding that her Zimmer implant had deteriorated and emitted metal shards into her hip.

On February 10, 2017, Adams brought a product liability action against Zimmer, the manufacturer of Adams’ former hip prosthesis.

In August 2018, a Pennsylvania U.S. District Court judge dismissed Adams’ claim because it missed Pennsylvania’s two-year statute of limitations. Adams appealed, arguing that the statute of limitations had not yet passed. Adams argued that the statute of limitations did not begin to run until her doctor actually performed her hip revision surgery.

On November 20, 2019, the Third Circuit Court of Appeals overturned the lower court’s 2018 ruling. In a two-to-one decision, the court ruled that a jury must decide if Marilyn Adams’ product liability suit against Zimmer, Inc. was filed too late.

Now, a jury will determine whether Adams was put on notice of her potential claim in January 2015 when her doctor suggested replacement surgery or in February 2015 when her doctor actually performed the surgery.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy